Image

Engaging Practices and Communities in the Development of Interventions to Promote HPV Vaccine Uptake

Engaging Practices and Communities in the Development of Interventions to Promote HPV Vaccine Uptake

Non Recruiting
9-26 years
All
Phase N/A

Powered by AI

Overview

The overarching goal of this project is to implement Boot Camp Translation (BCT) methodology to translate the guidelines and evidence for human papillomavirus (HPV) vaccine into a practice and provider level intervention designed to improve its acceptability and uptake.

Description

As a community engagement approach, Boot Camp Translation (BCT), is a 6-9-month iterative process that brings together multiple stakeholders, including patients, parents, and community members, to translate evidence-based guidelines and recommendations into locally relevant and meaningful messages, materials, and programs.

Aim 1: Implement BCT in three geographically distinct Colorado communities to translate the current evidence for HPV vaccination into locally relevant interventions designed to increase vaccine uptake.

Aim 2: Evaluate the impact of the BCT- designed intervention on practice-level HPV vaccination initiation rates.

The long-term goal is to develop a replicable approach and low-cost method of increasing HPV vaccine uptake that is easily adaptable to different settings and sociodemographic contexts.

Eligibility

Inclusion Criteria:

        All child patients who have received health supervision at participating practices during
        the 12 month prior to intervention and the 12 month following intervention implementation,
        who are ages 9-26 years, and whose parents have not requested removal from the Colorado
        Immunization Information System (CIIS) will be eligible for the assessment of practice
        immunization rates in the pre and post periods.
        Exclusion Criteria:
          -  No subjects will be excluded because of gender, ethnicity, or insurance status.
          -  Any child whose parents have requested removal from the immunization registry; any
             child with hypersensitivity to any component of one of the recommended vaccines; any
             child who has moved to a primary care provider other than one at the study clinics.

Study details
    Primary Prevention

NCT04279964

University of Colorado, Denver

20 August 2025

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.